Vaxart wins European patent covering oral norovirus vaccine technology
VXRT•European patent granted for oral norovirus vaccine technology
- Vaxart won a new European patent covering key technology behind its oral recombinant norovirus vaccine candidate.
- The European Patent Office published the grant of European Patent No. 3791859 effective today.
- Protection runs through at least 2036 across 13 European jurisdictions, including Germany, France, Italy, Spain, the UK.
- The patent covers aspects of Vaxart’s room-temperature stable, needle-free pill platform for norovirus.
